Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 218,238,974 papers from all fields of science
Search
Sign In
Create Free Account
Sebaceous adenoma
Known as:
ADENOMA, SEBACEOUS, BENIGN
, Sebaceous adenomas
, Adenoma of Sebaceous Gland
Expand
A benign, well circumscribed neoplasm arising from the sebaceous glands. It usually presents as a small yellowish tumor in the sun exposed skin of…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
20 relations
CDISC SEND Tumor Findings Results Terminology
Clinical Data Interchange Standards Consortium Terminology
Epithelial Cells
Epithelium
Expand
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2006
Highly Cited
2006
Distinction of Benign Sebaceous Proliferations From Sebaceous Carcinomas by Immunohistochemistry
E. Cabral
,
A. Auerbach
,
J. Killian
,
T. Barrett
,
D. Cassarino
American journal of dermatopathology
2006
Corpus ID: 11764540
Sebaceous lesions, including sebaceous hyperplasia, sebaceomas, and sebaceous adenomas and carcinomas, are histologically…
Expand
Highly Cited
2002
Highly Cited
2002
Sebaceoma and Related Neoplasms With Sebaceous Differentiation: A Clinicopathologic Study of 30 Cases
N. Misago
,
I. Mihara
,
S. Ansai
,
Y. Narisawa
American journal of dermatopathology
2002
Corpus ID: 34506192
The classification of benign sebaceous neoplasms has been challenged both by the assertion that sebaceous adenomas are really…
Expand
Highly Cited
2002
Highly Cited
2002
Microsatellite instability and immunostaining for MSH‐2 and MLH‐1 in cutaneous and internal tumors from patients with the Muir–Torre syndrome
P. Machín
,
L. Catasús
,
+7 authors
X. Matías-Guiu
Journal of cutaneous pathology
2002
Corpus ID: 12002846
Background: Muir‐Torre syndrome (MTS) is characterized by the co‐existence of sebaceous gland tumors of the skin and internal…
Expand
Highly Cited
1999
Highly Cited
1999
Cystic sebaceous tumors as marker lesions for the Muir-Torre syndrome: a histopathologic and molecular genetic study.
Arno Rütten
,
Walter H. C. Burgdorf
,
+5 authors
Roland Kruse
American journal of dermatopathology
1999
Corpus ID: 20753452
Cystic sebaceous tumors (CST) are well-circumscribed, large, deeply located dermal sebaceous proliferations with a cystic growth…
Expand
Review
1989
Review
1989
Neoplasia in ferrets: eleven cases with a review.
J. Dillberger
,
N. Altman
Journal of Comparative Pathology
1989
Corpus ID: 7655739
1988
1988
Unusual eyelid tumors with sebaceous differentiation in the Muir-Torre syndrome. Rapid clinical regrowth and frank squamous transformation after biopsy.
F. Jakobiec
,
L. Zimmerman
,
F. L. La Piana
,
A. Hornblass
,
R. A. Breffeilh
,
J. Lackey
Ophthalmology (Rochester, Minn.)
1988
Corpus ID: 39831928
Highly Cited
1984
Highly Cited
1984
Sebaceous Gland Tumors and Systemic Disease: A Clinicopathologic Analysis
S. Connolly
Medicine
1984
Corpus ID: 12294074
The association of sebaceous gland neoplasms with visceral carcinomas, first described by Muir and Torre, has become widely…
Expand
Review
1984
Review
1984
Torre's syndrome: report of two cases and review of the literature.
L. Banse-Kupin
,
A. Morales
,
M. Barlow
Journal of American Academy of Dermatology
1984
Corpus ID: 1555429
Highly Cited
1974
Highly Cited
1974
Cutaneous sebaceous neoplasms
D. B. Rulon
,
E. B. Helwig
Cancer
1974
Corpus ID: 30025921
Ninety‐five patients, each having a single cutaneous sebaceous neoplasm, were selected for study. Lesions of the eyelids were…
Expand
Review
1974
Review
1974
Multiple sebaceous adenomas and gastrointestinal carcinoma.
G. Sciallis
,
R. Winkelmann
Archives of Dermatology
1974
Corpus ID: 39077599
Two patients had sebaceous adenomas of the skin associated with adenocarcinoma of the gastrointestinal tract. Histopathologic and…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE